Kinnate Biopharma Cash from Investing (TTM) Insights

Kinnate Biopharma Inc (DELISTED) (KNTE:DL)

2.65 0.00 (0.00%) USD | NASDAQ | Apr 03, 16:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	109.87M
September 30, 2023	104.74M
June 30, 2023	79.06M
March 31, 2023	113.22M
December 31, 2022	-6.83M
September 30, 2022	-22.06M
June 30, 2022	-20.25M

Date	Value
March 31, 2022	-75.57M
December 31, 2021	-180.57M
September 30, 2021	-214.26M
June 30, 2021	-233.25M
March 31, 2021	-201.31M
December 31, 2020	-31.71M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-233.25M

Minimum

Jun 2021

113.22M

Maximum

Mar 2023

-44.53M

Average

-22.06M

Median

Sep 2022

Cash from Investing (TTM) Benchmarks